179 related articles for article (PubMed ID: 20714379)
21. Effect of a single 1200 Mg dose of Mucinex® on mucociliary and cough clearance during an acute respiratory tract infection.
Bennett WD; Kala A; Duckworth H; Zeman KL; Wu J; Henderson A; Yopp M; Rubin BK
Respir Med; 2015 Nov; 109(11):1476-83. PubMed ID: 26462765
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of HL301 in the treatment of acute bronchitis and acute exacerbation of chronic bronchitis: a phase 2, randomized, double-blind, placebo-controlled, multicenter study.
Park MJ; Rhee CK; Kim YH; Kim DJ; Kim DG; Lee SY; Kim JY
Curr Med Res Opin; 2017 May; 33(5):919-925. PubMed ID: 28277874
[TBL] [Abstract][Full Text] [Related]
23. [Value of ambroxol in treatment of bronchial asthma and spastic bronchitis].
Siergiejko Z; Obrzut D; Rogalewska A
Pol Tyg Lek; 1991 May 27-Jun 3; 46(22-23):424-7. PubMed ID: 1669082
[TBL] [Abstract][Full Text] [Related]
24. Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial).
Malerba M; Ponticiello A; Radaeli A; Bensi G; Grassi V
Pulm Pharmacol Ther; 2004; 17(1):27-34. PubMed ID: 14643168
[TBL] [Abstract][Full Text] [Related]
25. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
[TBL] [Abstract][Full Text] [Related]
26. Intraluminal inflammation in the airways of patients with chronic bronchitis after treatment with Ambroxol.
Lusuardi M; Capelli A; Salmona M; Tacconi MT; Cerutti CG; Donner CF
Monaldi Arch Chest Dis; 1995 Oct; 50(5):346-51. PubMed ID: 8541815
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of ambroxol hydrochloride lozenges in sore throat. Randomised, double-blind, placebo-controlled trials regarding the local anaesthetic properties.
Fischer J; Pschorn U; Vix JM; Peil H; Aicher B; Müller A; de Mey C
Arzneimittelforschung; 2002; 52(4):256-63. PubMed ID: 12040968
[TBL] [Abstract][Full Text] [Related]
28. Acebrophylline-induced angioedema.
Kuriachan S; Amberkar MB; Mohan MK; Shahul HA; Kishore MK
Indian J Pharmacol; 2015; 47(2):219-20. PubMed ID: 25878387
[TBL] [Abstract][Full Text] [Related]
29. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.
Grossman R; Mukherjee J; Vaughan D; Eastwood C; Cook R; LaForge J; Lampron N
Chest; 1998 Jan; 113(1):131-41. PubMed ID: 9440580
[TBL] [Abstract][Full Text] [Related]
30. [A study of the mechanism of Qingre Huatan therapy in treatment of acute exacerbation of chronic obstructive pulmonary disease by improving airway inflammation and mucus hypersecretion].
Li W; Mao B; Wang G; Wang L; Chang J; Zhang Y; Wan MH; Guo J
Zhong Xi Yi Jie He Xue Bao; 2008 Aug; 6(8):799-805. PubMed ID: 18664347
[TBL] [Abstract][Full Text] [Related]
31. [Modification of mucociliary clearance by a combination of theophylline with ambroxol and of ambroxol in monotherapy].
Dorow P; Weiss T
Arzneimittelforschung; 1988 Jun; 38(6):828-30. PubMed ID: 3052462
[TBL] [Abstract][Full Text] [Related]
32. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
33. Clinical trial with terbutaline and guajacol.
Brechter C
Scand J Respir Dis; 1973; 54(2):78-82. PubMed ID: 4575040
[No Abstract] [Full Text] [Related]
34. Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis.
Wilson R; Jones P; Schaberg T; Arvis P; Duprat-Lomon I; Sagnier PP;
Thorax; 2006 Apr; 61(4):337-42. PubMed ID: 16449273
[TBL] [Abstract][Full Text] [Related]
35. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
[TBL] [Abstract][Full Text] [Related]
36. [Rengalin, a novel drug for treatment of cough in children. Intermediate data on multicentre, comparative randomized clinical trial].
Geppe NA; Kondyurina EG; Galustyan AN; Pak TE; Baltserovich NB; Zhiglinskaya OV; Kamaev AV; Lazareva SG; Laleko SL; Melnikova IM; Mikhalkova EV; Perminova OA; Sabitov AU; Spivakovsky YM
Antibiot Khimioter; 2014; 59(7-8):16-24. PubMed ID: 25975103
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of Linkus, Aminophylline diphenhydramine and acefyllin piperazine for the treatment of cough in children.
Rehman H; Naveed S; Usmanghani K
Pak J Pharm Sci; 2016 May; 29(3 Suppl):1027-32. PubMed ID: 27383495
[TBL] [Abstract][Full Text] [Related]
38. Local anaesthetic properties of ambroxol hydrochloride lozenges in view of sore throat. Clinical proof of concept.
Schutz A; Gund HJ; Pschorn U; Aicher B; Peil H; Müller A; de Mey C; Gillissen A
Arzneimittelforschung; 2002; 52(3):194-9. PubMed ID: 11963647
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of Ascoril in the management of cough--National Study Group report.
Ainapure SS; Desai A; Korde K
J Indian Med Assoc; 2001 Feb; 99(2):111, 114. PubMed ID: 11482804
[TBL] [Abstract][Full Text] [Related]
40. The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data.
Cazzola M; Floriani I; Page CP
Pulm Pharmacol Ther; 2010 Apr; 23(2):135-44. PubMed ID: 19854285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
